Litcius/Paper detail

Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials

Olivia R. Ghosh‐Swaby, Shaun G. Goodman, Lawrence A. Leiter, Alice Cheng, Kim A. Connelly, David Fitchett, Peter Jüni, Michael E. Farkouh, Jacob A. Udell

2020The Lancet Diabetes & Endocrinology166 citationsDOI

Topics & Concepts

MedicineMeta-analysisMaceMyocardial infarctionType 2 diabetesHeart failureInternal medicineDiabetes mellitusRelative riskRandomized controlled trialClinical trialStroke (engine)MEDLINEIntensive care medicineConfidence intervalPercutaneous coronary interventionEndocrinologyMechanical engineeringLawEngineeringPolitical scienceDiabetes Treatment and ManagementLipoproteins and Cardiovascular HealthHeart Failure Treatment and Management